TRT Dose Calculator
Evidence-Based Testosterone Replacement Therapy Dosing Tool for Healthcare Professionals
This calculator is designed for healthcare professionals as a clinical decision support tool. Dosing recommendations are based on current medical literature and guidelines but must be individualized based on patient-specific factors, laboratory results, and clinical response. Always follow institutional protocols and use clinical judgment.
Patient Parameters
Patient age influences baseline testosterone and monitoring requirements
Used for dose adjustment calculations
SHBG affects free testosterone and dosing frequency optimization
Treatment Parameters
Half-lives: Cypionate/Enanthate ~4-5 days IM (some sources 7-9 days), Sustanon ~7 days (mixed esters), Gel ~1.3 hours. Model uses conservative mid-range estimates.
More frequent dosing reduces peak-to-trough variation
Target testosterone levels guide initial dosing
Dosing Recommendations
Predicted Serum Testosterone Levels (21-Day Profile)
Model assumptions: Exponential decay with dose superposition. Steady-state approached after ~4–5 half-lives. Red dots indicate injection times.
Recent Calculations (Last 5)
What is Testosterone Replacement Therapy (TRT)?
Testosterone Replacement Therapy (TRT) is a medically supervised treatment for men (and sometimes women) who have low levels of testosterone, aiming to restore optimal physiological levels and alleviate symptoms of androgen deficiency.
Common symptoms include fatigue, low libido, muscle loss, mood changes, and decreased bone density.
TRT may involve injections, gels, patches, or subdermal pellets, with dosing individualized per patient response and blood test results.
Most common agents: Testosterone Cypionate, Enanthate, Propionate, Sustanon (mixed esters) and topical gels.
| Formulation | Typical Dose & Frequency |
|---|---|
| Testosterone Cypionate | 75-150 mg IM/SC every 4-7 days |
| Testosterone Enanthate | 75-150 mg IM/SC every 4-7 days |
| Sustanon (mix) | 100-250 mg IM every 7-14 days |
| Testosterone Gel | 50-100 mg daily (topical) |
| Testosterone Propionate | 20-50 mg SC/IM every 1-3 days |
| Undecanoate | 1000 mg IM every 8-10 weeks |
| Measure | Reference Range |
|---|---|
| Total Testosterone (TT) | 264 – 916 ng/dL |
| Free Testosterone (fT) | 6.5 – 18.3 ng/dL |
| SHBG | 10 – 57 nmol/L |
Dose Calculation: Key Formulas
- Exponential decay for serum concentration: C(t) = C_0 × e-kt where k = ln(2)/half-life
- Steady-state is typically reached after 4-5 half-lives of continued dosing.
- Free Testosterone is estimated using: fT = TT / (SHBG × 0.0347 + 1.0)
- Peak-to-trough variation is minimized by more frequent dosing (e.g., splitting weekly dose into smaller, more frequent injections).
Clinical Guidelines & Best Practices
- Start patients at a conservative dose (e.g., 75-100 mg/week) and titrate up as needed based on symptom control and lab monitoring.
- Always pre-test for baseline TT, SHBG, CBC, and monitor every 3-6 months after initiation.
- Choose dosing interval tailored to patient lifestyle, SHBG levels, and response.
- For gels: apply daily and avoid transfer to others by covering treated skin.
- Patients with fertility concerns may need alternative approaches, as exogenous TRT suppresses endogenous testosterone.
- Watch for erythrocytosis, gynecomastia, and changes in mood or energy.
How This TRT Dose Calculator Helps
- Interactive dose selection and visualization tailored for clinicians and patients.
- Incorporates exponential decay and steady-state models for accurate dosing simulations.
- Accounts for patient age, weight, SHBG, agent formulation, and target concentration.
- Predicts injection timing and expected testosterone troughs and peaks.
- Improves safety by guiding toward stable, physiological dosing patterns instead of outdated protocols.
Result: Improved consistency, user-optimized protocols, and reduced risk of under/overdosing.
Step-by-Step Usage Guide
- Enter patient data: Age, weight, SHBG level, current TT.
- Select medication formulation and dosing interval.
- Set desired target testosterone range.
- Choose dose amount (mg) relevant to protocol.
- Review predicted concentration curve and injection schedule.
- Adjust input values iteratively to optimize for stable, therapeutic levels.
- Export results for documentation or quality review, if available.
Feature Overview
- Multi-agent coverage: cypionate, enanthate, propionate, gel, undecanoate.
- TRT dose visualization (no Chart.js/external libs).
- Responsive layout for mobile and desktop.
- Self-adjusting target references per SHBG/age.
- Secure, private – no patient data transmitted externally.
- Comprehensive documentation and built-in clinical formulas.
Model Assumptions
- Pharmacokinetics: exponential decay from dose, superposition for multiple doses.
- Steady-state: reached after 4-5 half-lives.
- Peak-to-trough depends on dosing schedule and agent half-life.
- SHBG effect incorporated for free testosterone calculation.
- All concentrations reference serum, not tissue levels.
Limitations
- Serum testosterone values may not reflect all clinical effects – consider symptoms and objectives.
- Does not address fertility protocols, pediatric dosing, or unusual comorbidities.
- Genetic, hepatic, and nutritional factors not accounted for in calculator model.
- Free testosterone calculation is an estimate; reference ranges vary.
- No substitute for clinician judgment and follow-up lab monitoring.
Best Practices
- Always monitor CBC, TT, fT, PSA, and hematocrit at baseline and follow-up.
- Individualize dosing frequency based on patient SHBG and preferences.
- Educate patients about injection technique and gel precautions.
- Document every change in protocol and reassess regularly.
Frequently Asked Questions (FAQs)
Recommended Tools & Libraries
- Vancomycin Dose Calculator
- Pediatric Dose Calculator
- Infusion Calculator
- Nurse Dose Calculator
- Dose Calculator Library
All tools are designed for clinical settings, optimized for client-side performance, easy integration, and strict compliance with healthcare standards.
Disclaimer
This calculator and documentation are provided for educational and informational purposes only. All clinical interventions should be supervised by a licensed healthcare professional. The model is not intended as a sole source for medical advice or therapy selection. Always confirm dosing decisions with current clinical guidelines and individual patient assessment.